| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |